The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Aug. 07, 2017
Applicant:

Y-biologics Inc., Daejeon, KR;

Inventors:

Jae Eun Park, Daejeon, KR;

Soo Young Kim, Daejeon, KR;

Hyun Mi Lee, Daejeon, KR;

Si Hyung Lee, Daejeon, KR;

Hyun Kyung Lee, Daejeon, KR;

Hye-Nan Kim, Daejeon, KR;

Jin Chui Youn, Daejeon, KR;

Bum-chan Park, Daejeon, KR;

Jung Chae Lim, Daejeon, KR;

Young-Gyu Cho, Daejeon, KR;

Young Woo Park, Daejeon, KR;

Assignee:

Y-BIOLOGICS INC., Daejeon, KR;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 35/00 (2006.01); C12N 15/85 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2818 (2013.01); A61K 35/00 (2013.01); C07K 16/2827 (2013.01); C12N 15/85 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C12N 2015/8518 (2013.01);
Abstract

Disclosed are an antibody to human programmed cell death 1 (PD-1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, an isolated cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer containing the same. The novel antibody binding to PD-1 or an antigen-binding fragment thereof can bind to PD-1 and inhibit the activity of PD-1, thus being useful for the development of immunotherapeutic agents for various diseases associated with PD-1.


Find Patent Forward Citations

Loading…